Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Ophthalmologica · 2024 · 247 (2) · 73-84
DOI: 10.1159/000536278 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ophthalmologica, online erschienen am 24.01.2024. Verfasst von Christoph R Clemens und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Muenster Medical Center, Muenster, Germany. Hauptthemen laut MEDLINE: Fluorescein Angiography, Macular Degeneration, Tomography, Optical Coherence. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: The aim of this review was to systematically summarize the current knowledge on type 3 macular neovascularization (MNV3) in age-related macular degeneration (AMD). Summary: Recent histopathologic and multimodal imaging findings led to the consensus definition of the new term “type 3 macular neovascularization” in AMD. MNV3 originates in the deep vascular plexus as a neovascular process without connection with the retinal pigment epithelium in the initial stages. This type has numerous clinical and pathomorphologic features that separate it from the other two types of MNV in AMD. Besides, its frequency appears to be higher than previously thought. In optical coherence tomography (OCT), MNV3 can be classified into stages 1–3. Hyperreflective foci in the outer retina possibly represent a precursor lesion. In addition, MNV3 is characterized by a strong association with reticular pseudodrusen, a high rate of bilaterality, close associations with advanced age and arterial hypertension, decreased choroidal thickness, and decreased choriocapillaris flow signals. Data from latest anti-vascular endothelial growth factor studies in MNV3 suggest that the OCT biomarkers in intraretinal and subretinal fluids should be interpreted differently than in the other types. Additionally, data from MNV3 eyes should be analyzed separately, allowing optimal type-specific treatment strategies in the future. Key Messages: This review highlights the need for accurate characterization of neovascular AMD lesions and an MNV type-specific approach, particularly for MNV3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Muenster Medical Center, Muenster, Germany.
Zitieren
APA
Clemens, C. R., Eter, N., & Alten, F. (2024). Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration. Ophthalmologica, 247(2), 73-84. https://doi.org/10.1159/000536278
Vancouver
Clemens CR, Eter N, Alten F. Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration. Ophthalmologica. 2024;247(2):73-84. doi:10.1159/000536278
BibTeX
@article{Clemens2024,
author = {Clemens, Christoph R and Eter, Nicole and Alten, Florian},
title = {Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration},
journal = {Ophthalmologica},
year = {2024},
volume = {247},
number = {2},
pages = {73--84},
doi = {10.1159/000536278}
}
EUVIMED